Anti-melanoma differentiation-associated gene 5 antibody-positive interstitial lung disease masquerading as rheumatoid arthritis-associated interstitial lung disease or overlapping with the same: a phenomenon driven by a probable genetic predisposition
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Rheumatoid arthritis with interstitial lung disease (RA-ILD) can be complicated by anti-MDA5 antibodies, impacting treatment. This review covers managing this rare overlap syndrome for better patient outcomes.
Area Of Science
- Rheumatology
- Immunology
- Pulmonology
Background
- Rheumatoid arthritis (RA) is a systemic autoimmune disease causing joint inflammation and functional disability.
- Extra-articular manifestations, including interstitial lung disease (ILD), are common in RA and increase morbidity/mortality.
- Anti-MDA5 antibodies, typically linked to dermatomyositis, can co-occur with RA, particularly in overlap syndromes, and affect ILD severity.
Purpose Of The Study
- To review the challenges in managing rheumatoid arthritis-interstitial lung disease (RA-ILD) coexisting with anti-MDA5 antibodies.
- To examine the pathophysiology, clinical presentation, diagnosis, therapy, and prognosis of RA-ILD and anti-MDA5-ILD.
- To discuss recent studies and recommendations for managing this complex condition.
Main Methods
- Case-based review approach.
- Literature search for studies on RA-ILD, anti-MDA5 antibodies, and overlap syndromes.
- Synthesis of information on disease mechanisms, clinical features, and treatment strategies.
Main Results
- Anti-MDA5 antibodies can complicate RA-ILD management, influencing disease severity and treatment response.
- Overlap syndromes involving RA, ILD, and anti-MDA5 antibodies present unique diagnostic and therapeutic challenges.
- Effective management requires a multidisciplinary approach, considering both RA and ILD aspects, as well as the impact of anti-MDA5 antibodies.
Conclusions
- Managing RA-ILD with anti-MDA5 antibodies requires careful consideration of the interplay between these conditions.
- Early diagnosis and tailored treatment strategies are crucial for improving prognosis in patients with this overlap syndrome.
- Further research is needed to optimize therapeutic approaches for RA-ILD associated with anti-MDA5 antibodies.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...